ALC

#375
Alcon Inc. Ordinary Shares
80.24 USD
+0.59%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
80.15
80.28
Intervallo Annuale
71.55
99.20
Variazione giornaliera
+0.59%
Variazione Mensile
+3.75%
Variazione di 6 mesi
+8.26%
Variazione Annuale
-12.66%
Chiusura Precedente
79.77
Apertura
80.19
Bid
Ask
Minimo
80.15
High
80.28
Volume
212
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 39.11 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Ricavi totali
Utile netto
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Notizie